Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Health Care's Hottest Duo
Motley Fool
Wednesday, December 21, 2011 - 9:01am
tags:
Gilead, Pharmasset, hepatitis C, Achillion, Inhibitex
Lundbeck seeks Europe approval for alcohol drug
Reuters
Wednesday, December 21, 2011 - 8:48am
tags:
Europe, Lundbeck, Selincro, alcoholism
Zogenix, Astellas to end co-promotion for migraine injection
Reuters
Wednesday, December 21, 2011 - 8:35am
tags:
Astellas, Zogenix, migraines, Sumavel DosePro
Takeda To Buy Small-Molecule Drug Maker For Up To $310 Million
WSJ Online
Tuesday, December 20, 2011 - 7:56pm
tags:
Takeda, small molecule drugs, M&A, Intellikine
What's Up With the Back-Slapping, Sequenom?
Motley Fool
Tuesday, December 20, 2011 - 7:51pm
tags:
Sequenom, Downs Syndrome, MaterniT21
AP Pharma's APF530 Poised To Return To FDA Review
Seeking Alpha
Tuesday, December 20, 2011 - 7:50pm
tags:
APF530, AP Pharma, FDA, chemotherapy-induced nausea and vomiting, CINV
FDA accepts application for Pfizer arthritis drug
Yahoo/AP
Tuesday, December 20, 2011 - 7:49pm
tags:
Pfizer, FDA, rheumatoid arthritis, tofacitinib
Generics makers step up for shortages response
Fierce Drug Manufacturing
Tuesday, December 20, 2011 - 12:12pm
tags:
generics, drug shortages
Progenics, Salix Surge After Constipation Drug Shows Benefits in Trial
Bloomberg
Tuesday, December 20, 2011 - 12:09pm
tags:
Salix, Progenics Pharmaceuticals, methylnaltrexone, opiod-induced constipation
Bayer predicts blockbuster success for four of its late-stage drugs
Fierce Biotech
Tuesday, December 20, 2011 - 11:24am
tags:
Bayer, Xarelto, VEGF Trap-Eye, regorafenib, Alpharadin
Teva Drops Most in a Month in Tel Aviv on U.S. Lipitor Sales
Bloomberg
Tuesday, December 20, 2011 - 11:22am
tags:
Teva Pharmaceuticals, Lipitor, generics
Prestige buys rights to GSK OTC meds for $660M
Fierce Pharma
Tuesday, December 20, 2011 - 11:15am
tags:
OTC, GSK, M&A, Prestige Brands
Novartis ends study of drug in high risk patients
Reuters
Tuesday, December 20, 2011 - 11:14am
tags:
Novartis, Tekturna, hypertension
10 Biotech Stock Predictions for 2012
TheStreet.com
Tuesday, December 20, 2011 - 11:13am
tags:
Amgen, FDA, Oncothyreon, Merck KGaA, Vical, GSK, Seattle Genetics, M&A, Celgene, Biomarin, Amag Pharmaceuticals, Momenta, ONYX Pharmaceuticals, Cell Therapeutics, Roche, Aeterna Zentaris, Arena Pharmaceuticals, Vertex, Spectrum Pharmaceuticals
Eli Lilly and Immunogen enter development deal for potential cancer treatments
Yahoo/AP
Tuesday, December 20, 2011 - 11:05am
tags:
Eli Lilly, Immunogen, Targeted Antibody Payload, cancer
Oncothyreon Files Investigational New Drug Application for ONT-10
Yahoo
Tuesday, December 20, 2011 - 11:04am
tags:
Oncothyreon, ONT-10, cancer, vaccines
What Can We Expect From CytRx In 2012?
Seeking Alpha
Tuesday, December 20, 2011 - 10:54am
tags:
CytRx, Bafetinib, INNO-206
Alexza And Somaxon: 2 Distressed Biotechs On Sale And Up For Sale
Seeking Alpha
Tuesday, December 20, 2011 - 10:51am
tags:
Somaxon, Alexza
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
Yahoo/AP
Tuesday, December 20, 2011 - 10:50am
tags:
antidepressants, Targacept, ovarian cancer, AstraZeneca, TC-5214, olaparib
Astra Zeneca Slides Towards the Patent Cliff
WSJ Online
Tuesday, December 20, 2011 - 10:33am
tags:
patents, AstraZeneca, Seroquel XR, Crestor

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.